IL17A and hypertensive disorder: In addition, utilizing animal models of hypertension, others have reported antagonism (genetic knockdown or neutralizing antibodies) of IL-17A reduced blood pressure and the incidence of target organ damage by acting on the vascular wall and tubular sodium transport [48].